Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service sleep apnea & airway implants cases in Colorado: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 15% on average (12 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2022 | 3 | 110 | 53% |
| 2023 | 6 | 184 | 55% |
| 2024 | 3 | 136 | 57% |
| 2025 from claims | – | 98 79–115 | 57% |
| 2026 forecast | – | 102 80–128 | 56% |
| 2027 forecast | – | 103 77–137 | 56% |
| 2028 forecast | – | 105 74–145 | 57% |
| 2029 forecast | – | 107 72–153 | 57% |
| 2030 forecast | – | 108 71–161 | 57% |
Hypoglossal nerve stimulation and upper airway procedures. Professional codes (what the surgeon bills): CPT 64582, 64583, 64584, 42145, 41530.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Colorado; 3 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% hospital outpatient.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| California | 8 | 343+39%/yr | +39%/yr | 0.1 | 11% | 410 in 2030+3.1%/yr |
| Arizona | 8 | 239+57%/yr | +57%/yr | 0.3 | 9% | 180 in 2030−4.4%/yr |
| Utah | 3 | 142+112%/yr | +112%/yr | 0.6 | 0% | 80 in 2030−8.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 19 | 2,002−1.7%/yr | −1.7%/yr | 4.20.9× | 85% | 2,650 in 2030+4.8%/yr |
| Cochlear implants | 4 | 157+3.7%/yr | +3.7%/yr | 0.32.0× | 0% | 110 in 2030−5.3%/yr |
| Ear tubes & middle ear surgery | 0 | 101−5.6%/yr | −5.6%/yr | 0.21.0× | 100% | 110 in 2030+2%/yr |
Sleep apnea & airway implants in every state, and its device makers · Every procedure market in Colorado · Every state · Compare with California
Inspire Medical Systems leads with 93% of company spending on these surgeons in 2025, −3 pts on 2024.
In 2025, 8 companies reported engagement with Colorado’s surgeons worth $185K in consulting, speaking, meals and travel tied to these products, about $62K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 18 clearances and approvals in the category, 2 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.